Global Papaverine Hydrochloride API market, valued at approximately USD 34.5 million in 2025, is projected to grow at a steady Compound Annual Growth Rate (CAGR) of 4.6%, reaching an estimated USD 51.8 million by 2034. The market's expansion is fueled by the rising incidence of cardiovascular and smooth muscle disorders, expansion in generic pharmaceutical manufacturing, growth in emerging...